Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05448196 · ClinicalTrials.gov registry record · NA
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT05448196 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 103 participants.
The verdict
NCT05448196, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
The study is a randomized controlled trial to develop and evaluate a coordinated financial navigation program at the Abramson Cancer Center (ACC) for patients with multiple myeloma and identify barriers to its broader implementation.
Interventions
- OTHER Coordinated Financial Navigation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2023-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05448196
The ClinicalTrials.gov registry entry for NCT05448196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coordinated Financial Navigation Program is the first listed.
NCT05448196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05448196 about?
NCT05448196 is a clinical study titled "Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma". The study is a randomized controlled trial to develop and evaluate a coordinated financial navigation program at the Abramson Cancer Center (ACC) for patients with multiple myeloma and identify barriers to its broader implementation.
What is the current status of trial NCT05448196?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2022-03-04. Estimated completion is 2023-06-22.
What interventions are being tested in trial NCT05448196?
The interventions under investigation include: Coordinated Financial Navigation Program (OTHER).
Who is sponsoring clinical trial NCT05448196?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.